Finance

Lists
Q3 2026 earnings • released • Revenue miss -4.72%
See results
4967:TYO
Kobayashi Pharmaceutical Co Ltd
Â¥7,056.00
+0.81%
(+57.00) 1D
Nov 13, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4967...
Open
Â¥6,992
High
Â¥7,064
Low
Â¥6,930
Mkt. cap
550.72B
Avg. vol.
270.62K
Volume
122.30K
Dividend
1.49%
Quarterly dividend
Â¥26
Ex-dividend date
Dec 29, 2026
P/E ratio
114.43
52-wk high
Â¥7,388
52-wk low
Â¥5,186
EPS
Â¥62
Shares outstanding
79.07M
No. of employees
4K
Open
Â¥6,992
High
Â¥7,064
Low
Â¥6,930
Mkt. cap
550.72B
Avg. vol.
270.62K
Volume
122.30K
Dividend
1.49%
Quarterly dividend
Â¥26
Ex-dividend date
Dec 29, 2026
P/E ratio
114.43
52-wk high
Â¥7,388
52-wk low
Â¥5,186
EPS
Â¥62
Shares outstanding
79.07M
No. of employees
4K
News stories
From web sources and news partners
About Kobayashi Pharmaceutical Co Ltd
CEOKazumasa Kobayashi
Employees3.73K
FoundedAug 22, 1919
Headquarters-
SectorConsumer Staples
IndustryPersonal care products
Last report
Nov 10, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (JPY)
42.74B / 44.86B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
53.70B
35.38B
37.08B
42.74B
Cost of goods sold
27.85B
17.21B
18.19B
20.79B
Cost of revenue
27.85B
17.21B
18.19B
20.79B
Research and development expenses
9.12B
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.76B
17.10B
18.08B
17.36B
Operating expense
22.50B
17.10B
18.04B
17.36B
Total operating expenses
50.36B
34.31B
36.23B
38.14B
Operating income
3.35B
1.06B
851.00M
4.60B
Other non operating income
-150.00M
-530.00M
20.00M
27.00M
EBT including unusual items
-5.52B
1.11B
483.00M
7.74B
EBT excluding unusual items
4.07B
829.50M
1.33B
4.45B
Income tax expense
-2.37B
541.00M
383.00M
1.14B
Effective tax rate
42.97%
48.76%
79.30%
14.68%
Other operating expenses
1.26B
-
-
-
Net income
-3.15B
568.00M
100.00M
6.60B
Net profit margin
-5.87%
1.61%
0.27%
15.44%
Earnings per share
-
-
-
-
Interest and investment income
448.00M
295.50M
454.00M
166.00M
Interest expense
-13.00M
-5.00M
-6.00M
-5.00M
Net interest expenses
435.00M
290.50M
448.00M
161.00M
Depreciation and amortization charges
3.89B
-
-
-
EBITDA
5.53B
3.45B
3.24B
6.79B
Gain or loss from assets sale
-
39.50M
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps